Takip et
Lauren M.F. Merlo
Lauren M.F. Merlo
mlhs.org üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Cancer as an evolutionary and ecological process
LMF Merlo, JW Pepper, BJ Reid, CC Maley
Nature reviews cancer 6 (12), 924-935, 2006
21002006
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
R Metz, C Smith, JB DuHadaway, P Chandler, B Baban, LMF Merlo, ...
International immunology 26 (7), 357-367, 2014
1922014
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma
LMF Merlo, NA Shah, X Li, PL Blount, TL Vaughan, BJ Reid, CC Maley
Cancer prevention research 3 (11), 1388-1397, 2010
1782010
IDO2 in immunomodulation and autoimmune disease
GC Prendergast, R Metz, AJ Muller, LMF Merlo
Frontiers in immunology 5, 119671, 2014
1352014
IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis
LMF Merlo, E Pigott, JB DuHadaway, S Grabler, R Metz, GC Prendergast, ...
The Journal of Immunology 192 (5), 2082-2090, 2014
1192014
Cancer in light of experimental evolution
K Sprouffske, LMF Merlo, PJ Gerrish, CC Maley, PD Sniegowski
Current Biology 22 (17), R762-R771, 2012
1082012
Differential roles of IDO1 and IDO2 in T and B cell inflammatory immune responses
LMF Merlo, JB DuHadaway, JD Montgomery, WD Peng, PJ Murray, ...
Frontiers in immunology 11, 544453, 2020
812020
The role of genetic diversity in cancer
LMF Merlo, CC Maley
The Journal of clinical investigation 120 (2), 401-403, 2010
752010
IDO2 modulates T cell–dependent autoimmune responses through a B cell–intrinsic mechanism
LMF Merlo, JB DuHadaway, S Grabler, GC Prendergast, AJ Muller, ...
The Journal of Immunology 196 (11), 4487-4497, 2016
532016
IDO2: a pathogenic mediator of inflammatory autoimmunity
LMF Merlo, L Mandik-Nayak
Clinical Medicine Insights: Pathology 9, CPath. S39930, 2016
522016
Development and characterization of an organotypic model of Barrett's esophagus
RE Kosoff, KL Gardiner, LMF Merlo, K Pavlov, AK Rustgi, CC Maley
Journal of cellular physiology 227 (6), 2654-2659, 2012
462012
Polyploidy, aneuploidy and the evolution of cancer
LMF Merlo, L Wang, JW Pepper, PS Rabinovitch, CC Maley
Polyploidization and cancer, 1-13, 2010
452010
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses
S Dey, E Sutanto-Ward, KL Kopp, J DuHadaway, A Mondal, D Ghaban, ...
Journal for immunotherapy of cancer 8 (2), 2020
432020
Therapeutic antibody targeting of indoleamine-2, 3-dioxygenase (IDO2) inhibits autoimmune arthritis
LMF Merlo, S Grabler, JB DuHadaway, E Pigott, K Manley, ...
Clinical Immunology 179, 8-16, 2017
432017
An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition
LMF Merlo, RE Kosoff, KL Gardiner, CC Maley
BMC cancer 11, 1-10, 2011
272011
Adaptive immunity: B cells and antibodies
LMF Merlo, L Mandik-Nayak
Cancer immunotherapy, 25-40, 2013
222013
The immunomodulatory enzyme IDO2 mediates autoimmune arthritis through a nonenzymatic mechanism
LMF Merlo, W Peng, JB DuHadaway, JD Montgomery, GC Prendergast, ...
The Journal of Immunology 208 (3), 571-581, 2022
142022
An empirical test of the concomitantly variable codon hypothesis
LMF Merlo, M Lunzer, AM Dean
Proceedings of the National Academy of Sciences 104 (26), 10938-10943, 2007
142007
Impact of IDO1 and IDO2 on the B cell immune response
LMF Merlo, W Peng, L Mandik-Nayak
Frontiers in immunology 13, 886225, 2022
112022
B-cell-targeted 3DNA nanotherapy against indoleamine 2, 3-dioxygenase 2 (IDO2) ameliorates autoimmune arthritis in a preclinical model
LMF Merlo, J Bowers, T Stefanoni, R Getts, L Mandik-Nayak
Clinical Pathology 13, 2632010X20951812, 2020
102020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20